Juvenile Diabetes Research Foundation Raises More Than $1 Million To Find Cure For Type 1 Diabetes

Top Quote Diane K. Adams; Allscripts Honored for Leadership, Dedication and Generosity. End Quote
  • Raleigh-Durham-Chapel Hill, NC (1888PressRelease) May 11, 2011 - The Juvenile Diabetes Research Foundation (JDRF) Triangle/Eastern N.C. Chapter raised more than $1 million to research the cause of and cure for juvenile (type 1) diabetes and its complications at its 8th annual Hope Gala (http://tekadvizor.com/JDRFNCGALA/), held on April 30 at the North Ridge Country Club in Raleigh. This represents more than a 50 percent increase over last year which was record-breaking for the Triangle/Eastern N.C. Chapter.

    The 2011 Living & Giving Award was awarded to Diane K. Adams, Executive Vice President, Culture and Talent at Allscripts, and her family for their leadership, generosity and dedication to improve the health and well-being of everyone affected by type 1 diabetes. Adams, who joined JDRF after her daughter, Danielle, was diagnosed with type 1 diabetes in 2000, serves on the JDRF International Board of Directors. With the support of family and friends, Danielle's walk team has raised more than $500,000 over the years, consistently placing as one of the top fundraising teams in the country.

    Allscripts (http://www.allscripts.com) was recognized as the 2011 Corporate Honoree for its continued contributions to JDRF, a signature cause for the company nationally. Allscripts, which employs more than 1,000 people in its Raleigh offices, provides technologies essential to creating a Connected Community of Health™ for more than 180,000 physicians, 1,500 hospitals and 10,000 post acute organizations worldwide.

    QUOTES:
    "A cure for type 1 diabetes is attainable, and we are excited to be able to contribute more than $1 million to additional research," said Andrea Ivarsson, chair of the 2011 Hope Gala. "JDRF is the largest charitable funder and advocate for diabetes science worldwide, and we are thankful for all of the contributions and support that we received from the local community at the Hope Gala."

    "Type 1 diabetes is a disease that impacts the whole family," said Adams. "The funds that were raised at the 2011 Hope Gala will take us one step closer to finding a cure."

    "An essential part of the Allscripts culture is giving back in the communities where we work and live," said Allscripts Chief Executive Officer Glen Tullman. "The generosity exhibited by those at the Gala and Allscripts team members has the potential to change the lives of many forever."

    NEW MEDIA CONTENT:
    JDRF Triangle Chapter Facebook:
    http://www.facebook.com/profile.php?id=100001181736841

    DETAILS:
    - Since its inception in 2004, the Hope Gala has become a focal point of the chapter's fundraising efforts, raising more than $4 million.

    - Allscripts has contributed more than $1 million to JDRF since 2004.

    - Seventy JDRF volunteers, committee members and staff contributed to the event.

    - The Gala's events included a cocktail reception, dinner party, and live and silent auctions.

    ABOUT JUVENILE DIABETES RESERCH FOUNDATION:
    JDRF is the leading charitable funder and advocate of type 1 (juvenile) diabetes research worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is a disease which strikes children suddenly and requires multiple injections of insulin daily or a continuous infusion of insulin through a pump. Insulin, however, is not a cure for diabetes, nor does it prevent its eventual and devastating complications which may include kidney failure, blindness, heart disease, stroke and amputation.

    Jennifer Fair
    MMI Public Relations
    (919) 233-6600
    jennifer ( @ ) mmipublicrelations dot com
    http://www.twitter.com/mmipr
    http://www.mmipublicrelations.com

    Claire Weingarden
    Allscripts
    (312) 447-2442
    claire.weingraden ( @ ) allscripts dot com

    ###
space
space
  • FB Icon Twitter Icon In-Icon
Contact Information